Skip to main content
Log in

Subakut sklerosierende Panenzephalitis nach Masernexposition im Säuglingsalter

Subacute sclerosing panencephalitis following exposure to measles in babyhood

  • Originalien
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Die subakut sklerosierende Panenzephalitis (SSPE) ist eine letal verlaufende Komplikation der Maserninfektion. Da der erste Masernkontakt oft schon vor der ersten Impfung erfolgt, kommt es immer wieder zu Erkrankungsfällen. Wir berichten von 2 betroffenen Kindern mit unterschiedlichen klinischen Verläufen.

Kasuistiken

Beide Patienten hatten im ersten Lebensjahr Kontakt mit an Masern erkrankten Kindern. Im Verlauf wurden beide gemäß den STIKO-Empfehlungen geimpft. Im Schulalter traten erste Krankheitssymptome auf. Es entwickelte sich eine schwere Enzephalopathie. Nur bei einem der Patienten bestand nach Diagnosestellung noch die Möglichkeit einer immunmodulatorischen Therapie, die zu einer passageren klinischen Verbesserung führte.

Schlussfolgerung

Die SSPE bleibt auch bei Kindern mit erfolgter Masernimpfung eine mögliche Differenzialdiagnose der unklaren progredienten Enzephalopathie. Prävention besteht nur in der konsequenten Immunisierung aller Kinder gegen Masern, um eine Minimierung der Ansteckungsgefahr, v. a. im ersten Lebensjahr, zu erreichen.

Abstract

Background

Subacute sclerosing panencephalitis (SSPE) is a lethal complication of measles virus infection. A risk factor for developing SSPE is measles exposure preceding the first vaccination. We report on two cases of SSPE with different clinical courses.

Case presentation

Both patients acquired an inapparent measles infection during their first year of life. They were vaccinated according to the current national recommendations. On reaching school age, early symptoms of SSPE were apparent and severe encephalopathy developed. Necrotizing chorioretinitis was observed in one of the patients. Only one patient was able to receive immunomodulatory treatment which induced transient clinical improvement.

Conclusion

SSPE should always be considered as a differential diagnosis in progressive encephalopathy in childhood. The disease can only be prevented by consistent measles vaccination in all children to minimize the risk of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Anlar B, Aydin OF, Guven A et al. (2004) Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis. Clin Ther 26: 1890–1894

    Article  PubMed  CAS  Google Scholar 

  2. Bellini WJ, Rota JS, Lowe LE et al. (2005) Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. J Infect Dis 192: 1686–1693

    Article  PubMed  Google Scholar 

  3. Dimova PS, Bojinova VS (2004) Case of subacute sclerosing panencephalitis with atypical absences and myoclonic-atonic seizures as a first symptom. J Child Neurol 19: 548–552

    PubMed  Google Scholar 

  4. Dyken PR (2001) Neuroprogressive disease of postinfectious origin: a review of a resurging subacute sclerosing panenzephalitis (SSPE). MRDD Res Rev 7: 217–225

    CAS  Google Scholar 

  5. Franz S, Kreth HW, Weissbrich B (2005) Epidemiological data on subacute sclerosing panencephalitis (SSPE) in Germany. Neuropediatrics 36: P42

    Google Scholar 

  6. Gascon GG (2003) Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. J Child Neurol 18: 819–827

    Article  PubMed  Google Scholar 

  7. Halsey NA, Modlin JF, Jabbour JT et al. (1980) Risk factors in subacute sclerosing panencephalitis: a case-control study. Am J Epidemiol 111: 415–424

    PubMed  CAS  Google Scholar 

  8. Jin L, Beard S, Hunjan R et al. (2002) Characterization of measles virus strains causing SSPE: a study of 11 cases. J Neurovirol 8: 335–344

    Article  PubMed  CAS  Google Scholar 

  9. Kalies H, Grote V, Schmitt HJ, Kries R von (2006) Immunisation status of children in Germany: temporal trends and regional differences. Eur J Pediatr 165: 30–36

    Article  PubMed  Google Scholar 

  10. Miyazaki M, Nishimura M, Toda Y et al. (2005) Long-term follow-up of a patient with subacute sclerosing panencephalitis successfully treated with intrathecal interferon alpha. Brain Dev 27: 301–303

    Article  PubMed  Google Scholar 

  11. Ozturk A, Gurses C, Baykan B et al. (2002) Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol 17: 25–29

    Article  PubMed  Google Scholar 

  12. Rima BK, Duprex WP (2005) Molecular mechanisms of measels virus persistence. Virus Res 111: 132–147

    Article  PubMed  CAS  Google Scholar 

  13. Robert Koch-Institut (2006) Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2006 des RKI. Robert Koch-Institut, Berlin

  14. Zagami AS, Lethlean AK (1991) Chorioretinitis as a possible very early manifestation of subacute sclerosing panencephalitis. Aust N Z J Med 21: 350–352

    PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Allmendinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allmendinger, A., Doege, C., Wolf, N. et al. Subakut sklerosierende Panenzephalitis nach Masernexposition im Säuglingsalter. Monatsschr Kinderheilkd 157, 55–60 (2009). https://doi.org/10.1007/s00112-008-1820-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-008-1820-x

Schlüsselwörter

Keywords

Navigation